Transitional cell carcinoma classification: Difference between revisions

	Transitional cell carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Transitional cell carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Cystoscopy and Bladder Biopsy
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Transitional cell carcinoma classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Transitional cell carcinoma classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Transitional cell carcinoma classification
CDC on Transitional cell carcinoma classification
Transitional cell carcinoma classification in the news
Blogs on Transitional cell carcinoma classification
Directions to Hospitals Treating Transitional cell carcinoma
Risk calculators and risk factors for Transitional cell carcinoma classification

← Older edit Newer edit →

VisualWikitext

Revision as of 15:03, 12 February 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Classification

Based on the growth pattern, transitional cell tumors may be classified into two subtypes:


Type	Description

Papillary urothelial carcinoma	Have slim finger-like projections that grow from the lining of the renal pelvis or ureter into the cavity
Flat urothelial carcinomas	Lay flat in the lining of the renal pelvis and ureter They grow deeper into the layers of the wall of the renal pelvis or ureter rather than into its cavity

WHO Classification

The World Health Organization in a collaborative effort conjointly with the International Society of Urological Pathologists (ISUP) published a consensus opinion classification system for urothelial (transitional cell) tumors:^[1]

Transitional cell tumors

Infiltrating urothelial carcinoma

with squamous differentiation
with glandular differentiation
with trophoblastic differentiation
Nested
Microcystic
Micropapillary
Lymphoepithelioma-like
Lymphoma-like
Plasmacytoid
Sarcomatoid
Giant cell
Undifferentiated

Non-invasive urothelial carcinoma

Urothelial carcinoma in situ
High grade papillary urothelial carcinoma
Low grade papillary urothelial carcinoma
Non-invasive papillary urothelial neoplasm of low malignant potential
Urothelial papilloma
Inverted urothelial papilloma

Grading

According to the WHO grading criteria, there are three grades of transitional cell carcinoma based on the degree of cellular differentiation:


Grade	Description

Low grade	Tumors with the least degree of cellular anaplasia compatible with a diagnosis of malignancy
High grade	Tumors with the most severe degrees of cellular anaplasia

References

↑ Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F (2002). "Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems". J Clin Pathol. 55 (12): 900–5. PMC 1769816. PMID 12461053.

Template:WH Template:WS

[pmid12461053-1] Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F (2002). "Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems". J Clin Pathol. 55 (12): 900–5. PMC 1769816. PMID 12461053.

[1]

@@ Line 56: / Line 56: @@
 ===Grading===
-According to the WHO grading criteria, there are three grades of transitional cell carcinoma based on the degree of cellular differentiation:<ref name="Grignon2009">{{cite journal|last1=Grignon|first1=David J|title=The current classification of urothelial neoplasms|journal=Modern Pathology|volume=22|year=2009|pages=S60–S69|issn=0893-3952|doi=10.1038/modpathol.2008.235}}</ref>
+According to the WHO grading criteria, there are three grades of transitional cell carcinoma based on the degree of cellular differentiation:
 {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px"
 |valign=top|
@@ Line 65: / Line 64: @@
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" |
-Grade 1
+Low grade
 | style="padding: 5px 5px; background: #F5F5F5;" align=left |
 *Tumors with the least degree of cellular anaplasia compatible with a diagnosis of malignancy
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" |
-Grade 2
+High grade
-| style="padding: 5px 5px; background: #F5F5F5;" align=left |
-*Histologic features between grades 1 and 3
-|-
-| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" |
-Grade 3
 | style="padding: 5px 5px; background: #F5F5F5;" align=left |
 *Tumors with the most severe degrees of cellular anaplasia